Source:http://www.reactome.org/biopax/48887BiochemicalReaction2918
| Predicate | Object |
|---|---|
| rdf:type | |
| biopax3:comment |
Authored: Jupe, S, 2010-10-14,
Edited: Jupe, S, 2011-06-10,
Reviewed: Herington, AC, 2011-06-13,
Reviewed: Waters, MJ, 2011-06-23,
The activation of Lyn by GHR is thought to indirectly activate ERK. Mutations of GHR predicted to disable a conformational change brought about by GH binding impaired ERK signaling but not JAK2/STAT5 signaling. ERK signaling was demonstrated to involve the Src family kinase Lyn (Rowlinson et al. 2008) and suggested to involve Src kinase dependent activation of Phospholipase C gamma and thereby Ras, similar to a mechanism proposed by Bivona et al. (2003). ERK activation mechanisms involving Src kinases and PLCgamma have been reported for the erythropoietin, thrombopoietin and prolactin receptors (Brooks & Waters 2010).
|
| biopax3:xref | |
| biopax3:dataSource | |
| biopax3:displayName |
Lyn activates ERK
|
| biopax3:eCNumber |
2.7.10.2
|
| biopax3:left | |
| biopax3:participantStoichio... | |
| biopax3:right |